Venus Viva has become the first procedure of its kind to receive FDA clearance for facial skin ablation and resurfacing by delivering nanofractional radio frequency into skin. Already a leading treatment in Europe, Asia and Canada, Venus Viva is a customizable solution for facial resurfacing that promises increased treatment options thanks to multi-applicators, superior radio-frequency depth penetration and consistent sectional dermal healing. It is now approved for use in the US.
“Based on our global clinical experience and market acceptance, Venus Viva has already established itself as ‘best-in-class’ technology,” says Domenic Serafino, chairman and CEO of Venus Concept, the product’s global distributor. “This minimally-invasive, nanofractional technology has been designed with patient comfort in mind. It incorporates Smart-Scan technology, allowing for tremendous clinical versatility and minimal downtime, while providing unparalleled patient comfort and satisfaction.”
According to doctors involved in the clinical trials of Venus Viva, there was great efficacy on a variety of different clinical indications, including excellent results on facial wrinkles with no downtime and a very high level of patient comfort and satisfaction.
So, if you’re on the hunt for an effective and minimally invasive way to deter signs of aging, Venus Viva is now a viable and FDA-cleared option.
